Literature DB >> 15906421

The impact of first-trimester screening on AMA patients' uptake of invasive testing.

Andrea M Wray1, Alessandro Ghidini, Collette Alvis, Jonathan Hodor, Helain J Landy, Sarah H Poggi.   

Abstract

OBJECTIVE: Prenatal testing for AMA includes invasive procedures such as CVS and amniocentesis, which have risks. We sought to determine the effects of first-trimester screening (FTS) on referrals for genetic counseling and patients' decisions to pursue invasive testing after FTS was offered in 2002.
METHODS: We compared AMA patients presenting for prenatal care who underwent early genetic counseling (<13 weeks' gestation) from 2001 to those from 2003. Charts were reviewed for maternal age, gestational age, past obstetric history, prior CVS or amniocentesis, abnormal ultrasound findings and decision to proceed with invasive testing. The two groups were compared using Student t-test and chi-square tests.
RESULTS: In 2001, 552 AMA women enrolled in prenatal care; 68 presented for early genetic counseling. In 2003, 728 AMA women enrolled in prenatal care; 172 presented for early genetic counseling. More counseled women chose genetic testing in 2003 than in 2001 (95% vs 79%, p<0.01). More patients elected an invasive procedure in 2001 compared to 2003 (71% vs 26%, p<0.01).
CONCLUSION: Availability of FTS results in more AMA women having early prenatal genetic counseling and choosing some form of genetic testing. Such women are less likely to choose invasive tests than those without access to FTS. Copyright (c) 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 15906421     DOI: 10.1002/pd.1144

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  9 in total

1.  Twin gestation pregnancies: genetic counseling and testing experience.

Authors:  Kathryn F Peters; Brian M Saltsman; Stephen A Petrill
Journal:  J Genet Couns       Date:  2006-04       Impact factor: 2.537

2.  Patients' Knowledge of Prenatal Screening for Trisomy 21.

Authors:  Michal Sheinis; Kira Bensimon; Amanda Selk
Journal:  J Genet Couns       Date:  2017-07-14       Impact factor: 2.537

3.  Chromosome abnormalities diagnosed in utero: a Japanese study of 28 983 amniotic fluid specimens collected before 22 weeks gestations.

Authors:  Miyuki Nishiyama; Jim Yan; Junko Yotsumoto; Hideaki Sawai; Akihiko Sekizawa; Yoshimasa Kamei; Haruhiko Sago
Journal:  J Hum Genet       Date:  2015-01-08       Impact factor: 3.172

4.  Factors that affect the decision to undergo amniocentesis in women with normal Down syndrome screening results: it is all about the age.

Authors:  Julia Grinshpun-Cohen; Talya Miron-Shatz; Liat Ries-Levavi; Elon Pras
Journal:  Health Expect       Date:  2014-05-12       Impact factor: 3.377

5.  Maternal age-based prenatal screening for chromosomal disorders: attitudes of women and health care providers toward changes.

Authors:  June C Carroll; Andrea Rideout; Brenda J Wilson; Judith Allanson; Sean Blaine; Mary Jane Esplen; Sandra Farrell; Gail E Graham; Jennifer MacKenzie; Wendy S Meschino; Preeti Prakash; Cheryl Shuman; Sherry Taylor; Stasey Tobin
Journal:  Can Fam Physician       Date:  2013-01       Impact factor: 3.275

6.  The utility of genetic counseling prior to offering first trimester screening options.

Authors:  L Brent Hafen; Rebecca S Hulinsky; Sara Ellis Simonsen; Stephanie Wilder; Nancy C Rose
Journal:  J Genet Couns       Date:  2009-05-28       Impact factor: 2.537

7.  A contingent model for cell-free DNA testing to detect fetal aneuploidy after first trimester combined screening.

Authors:  Carmen Cotarelo-Pérez; Raluca Oancea-Ionescu; Eloy Asenjo-de-la-Fuente; Dolores Ortega-de-Heredia; Patricia Soler-Ruiz; Pluvio Coronado-Martín; María Fenollar-Cortés
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-01-15

8.  The limited effect of information on Israeli pregnant women at advanced maternal age who decide to undergo amniocentesis.

Authors:  Julia Grinshpun-Cohen; Talya Miron-Shatz; Michal Berkenstet; Elon Pras
Journal:  Isr J Health Policy Res       Date:  2015-08-17

9.  The utilization and choices of aneuploidy screening in a midwestern population.

Authors:  Jeffrey M Dicke; Lindsey Van Duyne; Rachael Bradshaw
Journal:  J Genet Couns       Date:  2014-04-29       Impact factor: 2.537

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.